[1] Ahmad SM,Malik IA .1997 .TariqWUZ, eta! Hepatitis-Brelated chronicliverdiseasein Rawalpind-i Islamabaadrea. JCPSP, 7(2) : 43-6.
[2] .2000 .Relativferequencoyf hepatitisB virusand hepatiticC virusinfectionsin patientsof cirrhosiisn NWFP. JCPSP, 10(6) : 217-9.
[3] Shamsuddin S. .1998 .PortalSystemicencephalopathiyn chronicliverdisease:experienceof PeoplesMedical CollegeN, awabshahJ. CPSP, 8(2) : 53-55.
[4] .1988 .Progresisn thecontroolf viral hepatitism:emorandumfroma WHO meeting. BullWHO, 66 : 443-55.
[5] Seidal S,Stargel W .1989 .. Lancet, 2 : 234.
[6] Ml Khadim .1993 .Prevalencoef hepatitis-Bantigenin vari Virologicaplrofilesin patientwith multiplehepatitis ous populationgroupof NWFP. Clinicaalnd, 105 : 1529-33.
[7] Malik IA,Khan SA,Tariq WUZ .1998 .HepatitisC virus in perspectivew:heredo we stand. JCPSP, 6(40) : 5-186.
[8] Ryan KE,MclennanS KE,Barber JA,Alter MJ,Shafi T,Iqbal J,Ahmed S.,Prevalencoef S. . .MargolisHS, KrawezynskiK, eta! The natural anti-HCVblooddonors. nnIntern W1994, 2 : 1899-1905.
[9] Tang ZY,Yang BH,Secondarpyreventioonf BH . .. GastrotHepatol0, : 683-90.
[10] Maynord JE,Kane MA,Holder SC .1989 .Globalcontroolf hepatitisB through vaccine in the expanded programmeon Immunization. S 574, 11(suppl) : .
[11] Sung JL .1990 .8 Suppl:S 96-. The Asianregionalstudygroup. Vaccine, : .
[12] Fay OH. .1990 .8 (suppl):S 100-. , : discussioSn134-9.
[13] Shaikh MH,Shams K. Prevalencoef .1995 .HBV markerisn healthcarpersonnevlsmatchedcontrolJC. PSP, 5 : 19-21.
[14] .1989 .. Antibodies tohepatitisC virus.Lancet, 2 : 324-5.
[15] Bottelli R,Tibbals J,HockhouseDr J .1998 .Ultrasound screeningfor hepatocellulcaarrcinom ain cirrhosis: the evidencefor an establishedclinicalpractice. dinRadiol, 53 : 713-6.